在动态对静态平台倾斜过程中,进展性超核麻与异常性帕金森病中的头部位置控制策略
Stefan Kammermeier1, Kathrin Maierbeck1,2, Lucia Dietrich1,3
1Klinikum der Universität München, Ludwig-Maximilians-Universität, Neurologische Klinik und Poliklinik, München, Germany.
Frontiers in neurology
|May 1, 2025
概括
渐进性超核性麻 (PSP) 患者在平台倾斜时表现出明显增加的头部运动,与异常性帕金森病 (IPD) 患者和对照人群相比,表明稳定策略发生了变化. 这表明受损的感觉处理,而不是肌肉刚性,导致PSP下降.
科学领域:
- 神经科学是一个神经科学.
- 生物力学 生物力学
- 老年学是一门学科.
背景情况:
- 渐进性超核性麻 (PSP) 和异常性帕金森病 (IPD) 是神经退行性疾病,影响平衡,增加跌倒风险.
- 头部稳定对于在姿势挑战期间保持平衡至关重要.
- 了解头部稳定中的疾病特异性差异可以为预防跌倒的策略提供信息.
研究的目的:
- 在被动平台倾斜过程中调查和比较PSP,先进IPD和健康对照个体的头部稳定策略.
- 确定导致疾病特异性下降模式的因素.
主要方法:
- 17名PSP患者,11名IPD患者和18名健康对照参与了这项研究.
- 试验对象接受了被动的前后平台倾斜,并使用多频率的伪随机刺激.
- 记录了三维体段运动,并分析了平台倾斜和体段反应之间的转移函数.
主要成果:
- 与IPD患者和对照人群相比,PSP患者在太空中的头部游览量是PSP患者的几倍.
- 转移函数的收益,代表刺激驱动的头部运动,在PSP中显著更高.
- 头部稳定增益在中间倾斜频率 (0.15-0.4 Hz) 最高,不受眼睛状况的影响.
结论:
- 在PSP中增加的头部外出是由于中央,自我中心,自觉主导的稳定策略,而不是不特定的稳定性或部刚性的缺乏.
- 在处理视觉和前庭信息方面的缺陷是导致PSP下降的关键因素,比以前认识到的要多.
- 这些发现突显出明显的感官处理缺陷,是PSP与IPD的余额损失的基础.
相关概念视频
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Parkinson's Disease: Overview
308
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
308


